Perceptive Advisors’s Kura Oncology KURA Stock Holding History

Perceptive Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-48,200	Closed	-$1.03M	–	121
2024 Q1	$1.03M	Buy	+48,200	New	+$937K	0.02%	105

Other funds holding KURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Perceptive Advisors's KURA Position: Q2 2024 in Review

Perceptive Advisors sold out of Kura Oncology (KURA) in Q2 2024, closing a stake of 48,200 shares — an estimated $1.03M sold.

Perceptive Advisors first reported a position in KURA in Q1 2024 and held it in 1 quarter. The position peaked at $1.03M in Q1 2024. 174 funds tracked by Wall St. Rank hold KURA as of Q2 2024.

Perceptive Advisors reported no remaining Kura Oncology position as of Q2 2024 after selling out during the quarter.
Perceptive Advisors sold 48,200 Kura Oncology shares in Q2 2024, an estimated $1.03M.
Perceptive Advisors first reported a position in Kura Oncology in Q1 2024 and held it in 1 quarter.
Perceptive Advisors's Kura Oncology position peaked at $1.03M in Q1 2024.
174 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2024.

Based on Perceptive Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.